Table 2.
Evaluation of chronic dextran sulphate sodium (DSS)-induced colitis in BALB/c mice orally treated with Parabacteroides distasonis components.
| Experimental group | Colon length (cm) | Disease activity index | Histological grade | Serum haptoglobin (g/l) |
|---|---|---|---|---|
| PBS | 6·25 ± 0·37 | 3·08 ± 0·39 | 1·56 ± 0·35 | 0·91 ± 0·60 |
| mPd | 6·79 ± 0·51* | 2·25 ± 0·56* | 1·59 ± 0·28 | 0·20 ± 0·15** |
| cPd | 6·46 ± 0·40 | 3·08 ± 0·39 | 1·63 ± 0·31 | 0·09 ± 0·05** |
| LPS | 6·96 ± 0·34* | 2·82 ± 0·65 | 1·51 ± 0·37 | 0·06 ± 0·02** |
| PBS without DSS | 9·22 ± 0·83** | 0·73 ± 0·26** | 0·14 ± 0·14** | 0·01 ± 0·01** |
| mPd without DSS | 8·89 ± 0·60** | 0·45 ± 0·40** | 0·32 ± 0·20** | 0·01 ± 0·01** |
Data are representative of one experiment. Similar results were obtained from two independent experiments. Values are expressed as means ± standard deviation (10 mice per group). One-way analysis of variance with Dunnett's multiple comparison test was used to evaluate differences between experimental groups and phosphate-buffered saline (PBS)-treated controls (
P < 0·05;
P < 0·01). mPd: membranous fraction of P. distasonis; cPd: cytoplasmic fraction of P. distasonis lysate; LPS: lipopolysaccharide.